Seite 1 von 59 Asthma Leitlinie: Referenzen [www.evidence.de ...

More documents

Recommendations

Info

Asthma Leitlinie: Referenzen [www.evidence.de] evidenzbasierte Leitlinien 597.Turner, E. S., Greenberger, P. A., and Patterson, R., Management of the pregnant asthmatic patient. Ann Intern Med, 1980. 93(6): p. 905-18. Evidenzklasse: IV Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6778281 598.Turner, M. O., et al., Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med, 1998. 157(6 Pt 1): p. 1804-9. Evidenzklasse: III Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9620909 599.Turner, M. O., et al., A randomized trial comparing peak expiratory flow and symptom self- management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med, 1998. 157(2): p. 540-6. Evidenzklasse: Ib Link: http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ajrccm.org/cgi/content/full/157/2/540 600.Udwadia, Z. F. and Harrison, B. D., An attempt to determine the optimal duration of hospital stay following a severe attack of asthma. J R Coll Physicians Lond, 1990. 24(2): p. 112-4. Evidenzklasse: III Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2352195 601.Ukena, D., et al., [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance]. Pneumologie, 1997. 51(3): p. 317-23. Evidenzklasse: Ib Link: 602.Ulrik, C. S., et al., Risk factors for development of asthma in children and adolescents: findings from a longitudinal population study. Respir Med, 1996. 90(10): p. 623-30. Evidenzklasse: III Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8959120 603.van der Heide, S., et al., Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol, 1999. 104(2 Pt 1): p. 447-51. Evidenzklasse: Ib Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10452769 604.van der Molen, T., et al., Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am J Respir Crit Care Med, 1998. 158(1): p. 121-5. Evidenzklasse: Ib Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9 655717 605.van der Molen, T., et al., Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. Thorax, 1997. 52(6): p. 535-9. Evidenzklasse: Ib Link: 606.Van Ganse, E., et al., Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J, 1997. 10(10): p. 2216-24. Evidenzklasse: Ia Link: 607.van Grunsven, P. M., et al., Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma, 2000. 37(3): p. 225-34. Evidenzklasse: Ib http://www.evidence.de/Leitlinien/leitlinien-intern/Asthma_Start/Asthma_Referenzen... Seite 54 von 59 09.07.2005
Asthma Leitlinie: Referenzen [www.evidence.de] evidenzbasierte Leitlinien Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10831147 608.van Noord, J. A., et al., Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax, 1999. 54(3): p. 207-12. Evidenzklasse: Ib Link: http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.thoraxjnl.com/cgi/content/full/54/3/207 609.van Noord, J. A., et al., Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J, 1996. 9(8): p. 1684-8. Evidenzklasse: Ib Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8866595 610.Venables, K. M., et al., Peak flow rate records in surveys: reproducibility of observers' reports. Thorax, 1984. 39(11): p. 828-32. Evidenzklasse: III Link: 611.Verberne, A. A., et al., One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med, 1997. 156(3 Pt 1): p. 688-95. Evidenzklasse: Ib Link: http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/referer?http://www.ajrccm.org/cgi/content/full/156/3/688 612.Villa, J. R., et al., Serum eosinophilic cationic protein may predict clinical course of wheezing in young children. Arch Dis Child, 1998. 78(5): p. 448-52. Evidenzklasse: III Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9659092 613.von Mutius, E., et al., Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax, 2001. 56(11): p. 835-8. Evidenzklasse: Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1 1641506 614.Voshaar, Th. et al, Empfehlungen für die Auswahl von Inhalationssystemen zur Medikamentenverabreichung. Pneumologie, 2001. 55: p. 579-586. Evidenzklasse: IV Link: 615.Waalkens, H. J., et al., Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis, 1993. 148 (5): p. 1252-7. Evidenzklasse: Ib Link: 616.Walters, EH and Walters, J, Inhsled short acting beta 2 agonisten use in asthma:regular versus as needed treatment (Cochrane Review). The Cochrane Library, 2001(3). Evidenzklasse: Link: 617.Ward, M. J., et al., Ipratropium bromide in acute asthma. Br Med J (Clin Res Ed), 1981. 282(6264): p. 598-600. Evidenzklasse: III Link: 618.Ward, MJ., The role of anti-cholinergic drugs in acute asthma, in Anticholinergic Therapy in Obstructive Airways Disease, G. NJ, Editor. 1993, Franklin Scientific: London. p. 155-62. Evidenzklasse: IV Link: http://www.evidence.de/Leitlinien/leitlinien-intern/Asthma_Start/Asthma_Referenzen... Seite 55 von 59 09.07.2005
Page 1 and 2:
Asthma Leitlinie: Referenzen [www.e
Page 3 and 4: Asthma Leitlinie: Referenzen [www.e
Page 53: Asthma Leitlinie: Referenzen [www.e
Page 59: Asthma Leitlinie: Referenzen [www.e
show all

Seite 1 von 59 Asthma Leitlinie: Referenzen [www.evidence.de ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?